One Case of Lower Limb Edema Caused by Fuzhiqing Ointment

doi:10.19803/j.1672-8629.20260104

Abstract

Abstract: Objective To explore the adverse reactions induced by Fuzhiqing ointment and provide a reference for its clinical application. Methods One case of a patient with cerebral infarction complicated with mixed hemorrhoids, thrombotic external hemorrhoids, constipation, and chronic anorectal inflammation was analyzed. The patient developed bilateral lower limb edema after 12 days of topical application of Fuzhiqing ointment. The possible causes, as well as corresponding prevention and treatment measures, were explored. Results The lower limb edema in this patient was likely associated with the prolonged topical use of Fuzhiqing ointment. The symptoms of the patient improved significantly 2 days after drug withdrawal and completely disappeared one week after drug withdrawal. Conclusion Clinicians should be alert to the risk of lower limb edema among patients who chronically use Fuzhiqing ointment, and ensure its rational use.

Key words: Fuzhiqing Ointment, Mixed Hemorrhoids, Lower Limb Edema, Adverse Drug Reaction

CLC Number:

R282
R994.11

WANG Hao, PAN Peng, QIN Haijun, WANG Jianping. One Case of Lower Limb Edema Caused by Fuzhiqing Ointment[J]. Chinese Journal of Pharmacovigilance, 2026, 23(6): 699-701.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.20260104

https://zgywjj.magtechjournal.com/EN/Y2026/V23/I6/699

References

[1] LI KQ, XU J.Clinical Observation on the Treatment of Perianal Eczema Damp Heat Immersion Type with Modified Huopu Xialing Decoction Combined with Fuzhiqing Ointment[J]. Journal of Practical Traditional Chinese Medicine(实用中医药杂志), 2025, 41(1): 30-32.
[2] YU SH, LIU WH, YUAN Y, et al.Study on Efficacy and Safety of Ozone Hydrotherapy Combined with Fuzhiqing Ointment in the Treatment of Acute and Subacute Eczema in Children[J]. Journal of China Prescription Drug(中国处方药), 2025, 23(2): 72-76.
[3] YE ZH, LI YM, MO YH, et al.Clinical Study on the Combination of Golden Place and Fuzhiqing Ointment with Traditional Chinese and Western Medicine for Postoperative Rehabilitation of Internal Hemorrhoids[J]. Modern Interventional Diagnosis and Treatment in Gastroenterology(现代消化及介入诊疗), 2024, 29(7): 821-824.
[4] WANG Y, ZHANG QN, CHAI YY.Observation on the Efficacy of Sanhuang Lotion Combined with Fuzhiqing Ointmentin Treating Perianal Eczema of Dampness-Heat Downward Pouring Type[J]. Shanghai Medical & Pharmaceutical Journal(上海医药), 2025, 46(10): 47-50.
[5] CUI X, YANG DQ, XIE ZN, et al.Pharmacovigilance Guidelines for Clinical Application of Chinese Patent Medicines for External Use[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2024, 49(16): 4285-4290.
[6] WU F.Multi-Dimensional Thinking on TCM Etiology and Pathogenesis of Constipation[J]. Clinical Journal of Chinese Medicine(中医临床研究), 2024, 16(27): 140-143.
[7] YUAN R, JIANG Y, LEI L, et al.Treatment of Internal Hemorrhoid Hemorrhage and Prolapse with Yizi Decoction Based on“the Ascending and Descending Theory”of Traditional Chinese Medicine[J]. China Medical Herald(中国医药导报), 2022, 19(32): 112-116.
[8] YE Q, CHEN JP, LING Y, et al.Research Progress on Chemical Constituents and Pharmacological Effects of Ardisiae Crenatae Radix[J]. Chinese Traditional and Herbal Drugs(中草药), 2022, 53(9): 2851-2860.
[9] WANG JP, YANG Y, LIU Y, et al.The Application of Traditional Chinese Medicine Formulations in Burn Treatment[J]. China Pharmacy(中国药房), 2015, 26(35): 5038-5040.
[10] WANG JP.Study of Toxic Substanse of Rhubarb[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy(中国民族民间医药), 2011, 20(24): 63-64.
[11] YE JF.Analysis of Clinical Characteristics of Adverse Reactions of Traditional Chinese Medicine Preparations[J]. Chin J Mod Drug(中国现代药物应用), 2024, 18(14): 152-154.
[12] LIU GY, BAI L, MIAO SM.External Application Characteristics of 42 Toxic Traditional Chinese Medicines in the 2020 Edition of the Chinese Pharmacopoeia[J]. Pharmacology and Clinics of Chinese Materia Medica(中药药理与临床), 2024, 40(4): 115-120.
[13] ZHAO J, ZHANG HZ, LI GX.Analysis on Present Situation of ADR of Traditional Chinese Medicine for External Use[J]. Chinese Journal of Information on TCM(中国中医药信息杂志), 2015, 22(4): 132-136.
[14] LU ZK, YANG DQ, XIE ZN, et al.Interpretation and Insights from the“Guidelines for Pharmacovigilance of Topical Traditional Chinese Medicines in Clinical Applications”[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2024, 21(9): 1029-1033.

[1]	WANG Chunting, ZHANG Ruifang, DENG Bin, ZOU Zhenlei, WANG Kun. Adverse Reactions Induced by Iron Dextran Injection [J]. Chinese Journal of Pharmacovigilance, 2026, 23(6): 672-676.
[2]	PAN Yanjuan, YUE Kexin, LIU Weijie, WANG Lingjun, WANG Chuansheng. 243 Reports of Adverse Drug Reactions Associated with Olanzapine [J]. Chinese Journal of Pharmacovigilance, 2026, 23(6): 677-680.
[3]	WANG Yuting, LYU Xinge, PAN Chen, WU Yi, CUI Xiangli. Reports of Adverse Reactions of Immune Checkpoint Inhibitor-Related Colitis [J]. Chinese Journal of Pharmacovigilance, 2026, 23(6): 681-685.
[4]	WEN Ranmiao, CHEN Yue, YANG Caihua. Two Cases of Acute Generalized Exanthematous Pustulosis Caused by Clindamycin Hydrochloride Injection during the Perinatal Period [J]. Chinese Journal of Pharmacovigilance, 2026, 23(6): 686-689.
[5]	LI Hualong, WANG Lingfeng, LU Qian. One Case of Scrotal Inflammation with Local Necrosis Caused by Dapagliflozin Tablets [J]. Chinese Journal of Pharmacovigilance, 2026, 23(6): 690-692.
[6]	LAN Zhihui, BU Lijia, NING Jie, JIANG Jiemei, YANG Yanbiao. One Case of Autoimmune Hemolytic Anemia Caused by Camrelizumab for Injection [J]. Chinese Journal of Pharmacovigilance, 2026, 23(6): 696-698.
[7]	LIU Ying, XUE Hongwei, PANG Nan, YANG Zhongyi, KE Wenyuan, LIU Ling. Analysis of 445 Reports of Severe Adverse Drug Reactions to Bevacizumab Injection [J]. Chinese Journal of Pharmacovigilance, 2026, 23(5): 547-552.
[8]	DU Yan, YANG Chunlan, SUN Xuqun, FANG Ling. Analysis of 121 Reports of Adverse Drug Reactions to PD-1/PD-L1 Inhibitors [J]. Chinese Journal of Pharmacovigilance, 2026, 23(5): 553-557.
[9]	LI Xingqiao, MA Sijia. Signal Analysis of Adverse Drug Reactions of Statins Based on Real-World Data [J]. Chinese Journal of Pharmacovigilance, 2026, 23(5): 558-563.
[10]	WEI Wei, QUAN Qinbo, WANG Linghua, TIAN Yuejie, HUANG Lin, LI Na, WANG Weibo. Visualization of Real-World Adverse Drug Reaction Based on a Traditional Chinese Medicine Preparation as Empirical Evidence [J]. Chinese Journal of Pharmacovigilance, 2026, 23(5): 564-568.
[11]	ZOU Rui, WU Yutong, ZHOU Yue, LI Qin, MENG Zhaoyou. One Case of Myasthenia Gravis with Acute Myocarditis Caused by Toripalimab Injection [J]. Chinese Journal of Pharmacovigilance, 2026, 23(5): 569-571.
[12]	TANG Liu, LI Yang, LUO Guangwen, BAO Yindi. One Case of Drug-Induced Liver Injury Caused by Linezolid Injection [J]. Chinese Journal of Pharmacovigilance, 2026, 23(5): 572-574.
[13]	DAI Biao, ZHANG Song, DENG Yiyun, CAO Yin, ZHANG Yuanyuan, LI Peipei, LIANG Jun. One Case of Agranulocytosis Caused by Tiopronin Enteric-Coated Capsules [J]. Chinese Journal of Pharmacovigilance, 2026, 23(5): 575-577.
[14]	WANG Aming, WEI Xiao, WU Hui, ZHANG Linlin, YANG Li. One Case of Acute Hepatic Injury Caused by Pregabalin Capsules [J]. Chinese Journal of Pharmacovigilance, 2026, 23(5): 578-580.
[15]	ZHANG Qin, ZHENG Xiaoyuan. One Case of Joint Pain and Muscle Weakness Caused by Dupilumab Injection [J]. Chinese Journal of Pharmacovigilance, 2026, 23(5): 581-584.